Predicting Tolerance to Radiation Therapy in Older Adults With Cancer
A comprehensive geriatric assessment tool developed by Hurria and colleagues has been used in non-radiation oncology clinical settings to predict how older adults tolerate cancer treatments. The investigators think this same tool (referred to as the CGA) can be used in a radiation oncology clinic to predict for poor treatment tolerance.
Checked against the public recordLast updated Jun 4, 2018 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Not specified
- Study type
- Observational
- Phase
- Not applicable
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Interventions being studied
- Not specified
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * ≥Age 65 years (no upper age limit) * Diagnosis of either head and neck cancer, or lung cancer with either radiotherapy or chemoradiotherapy planned as part of standard treatment. * Consented for receipt of External Beam Radiation Therapy (EBRT) at UNC Chapel Hill * Able to read English (required for CGA) * Curative treatment intent as defined by their radiation oncologist Signed, IRB-approved written informed consent * Patients enrolled in other CGA studies will not be excluded (see LCCC 0916, 1208) Exclusion Criteria: * ≥Age 65 years (no upper age limit) * Diagnosis of either head and neck cancer, or lung cancer with either radiotherapy or chemoradiotherapy planned as part of standard treatment. * Consented for receipt of EBRT at UNC Chapel Hill * Able to read English (required for CGA) * Curative treatment intent as defined by their radiation oncologist Signed, IRB-approved written informed consent * Patients enrolled in other CGA studies will not be excluded (see LCCC 0916, 1208)
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Radiation Oncology Clinic - UNC Cancer HospitalChapel Hill, North Carolina
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jun 4, 2018. Always confirm current availability with the study team.